<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Spire Healthcare Group Plc — News on 6ix</title>
<link>https://6ix.com/company/spire-healthcare-group-plc</link>
<description>Latest news and press releases for Spire Healthcare Group Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Apr 2026 11:06:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/spire-healthcare-group-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835ebef78dffbe2df12aea1.webp</url>
<title>Spire Healthcare Group Plc</title>
<link>https://6ix.com/company/spire-healthcare-group-plc</link>
</image>
<item>
<title>Dividend Declaration</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/dividend-declaration-428</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/dividend-declaration-428</guid>
<pubDate>Tue, 14 Apr 2026 11:06:00 GMT</pubDate>
<description>Spire Healthcare Group plc has announced a final dividend of 1.5 pence per ordinary share in GBP. The ex-dividend date is set for 21 May 2026, with a record date of 22 May 2026, and the dividend is scheduled to be paid on 19 June 2026.
Disclaimer*</description>
</item>
<item>
<title>Notice of AGM and Annual Financial Report</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/notice-of-agm-and-annual-financial-report</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/notice-of-agm-and-annual-financial-report</guid>
<pubDate>Thu, 09 Apr 2026 11:48:00 GMT</pubDate>
<description>Spire Healthcare Group plc has published its 2025 Annual Report and Notice of 2026 Annual General Meeting, following its preliminary results announcement on March 5, 2026. The company has made these documents available on its website and submitted them to the National Storage Mechanism for regulatory compliance. The 2026 Annual General Meeting is scheduled for May 14, 2026, at 3 Dorset Rise, London EC4Y 8EN, with shareholders encouraged to attend in person and submit questions via email to compa</description>
</item>
<item>
<title>Disclosure Table</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/disclosure-table-22</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/disclosure-table-22</guid>
<pubDate>Mon, 23 Mar 2026 07:45:00 GMT</pubDate>
<description>The Takeover Panel has updated its Disclosure Table, noting no additions but a deletion related to Bridgepoint Advisers Limited as a potential offeror for Spire Healthcare Group plc, with its Rule 2.6 deadline having passed. The table also details ongoing offer periods for several companies including IQE plc with 979,064,894 ordinary shares, NCC Group plc with 295,709,196 ordinary shares, and WH Ireland Group plc with 242,873,891 ordinary shares, among others, with various offerors identified an</description>
</item>
<item>
<title>Update on Strategic Review</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/update-on-strategic-review-4</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/update-on-strategic-review-4</guid>
<pubDate>Mon, 23 Mar 2026 07:00:00 GMT</pubDate>
<description>Spire Healthcare Group plc announced that conversations with Bridgepoint and Triton regarding a possible offer for the company have terminated, though the Board remains in discussions with other parties about a potential sale. The company is also actively evaluating other actions to drive long-term shareholder value and remains in an "Offer Period" as defined by the City Code on Takeovers and Mergers.
Disclaimer*</description>
</item>
<item>
<title>Announcement made following a related announcement</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/announcement-made-following-a-related-announcement</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/announcement-made-following-a-related-announcement</guid>
<pubDate>Fri, 20 Mar 2026 18:19:00 GMT</pubDate>
<description>Triton Investments Advisers LLP has announced that it does not intend to make a firm offer for Spire Healthcare Group plc, following previous discussions related to Spire Healthcare's strategic review. This statement is made under Rule 2.8 of the City Code on Takeovers and Mergers, which imposes restrictions on Triton and its concert parties from making further offers for Spire Healthcare for a period of six months, unless certain exceptions apply, such as agreement from Spire Healthcare's board</description>
</item>
<item>
<title>Statement regarding Spire Healthcare Group</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/statement-regarding-spire-healthcare-group</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/statement-regarding-spire-healthcare-group</guid>
<pubDate>Fri, 20 Mar 2026 17:16:00 GMT</pubDate>
<description>Bridgepoint Advisers Limited has announced that it does not intend to make an offer for Spire Healthcare Group plc, following its participation in the Formal Sale Process. Bridgepoint stated it was unable to achieve sufficient confidence in a transaction structure that would be suitable for all stakeholders at this time. As a result of this announcement, Bridgepoint is now bound by Rule 2.8 of the UK City Code on Takeovers and Mergers, which restricts it from making or participating in an offer </description>
</item>
<item>
<title>Director/PDMR Shareholding</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/directorpdmr-shareholding-726</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/directorpdmr-shareholding-726</guid>
<pubDate>Wed, 18 Mar 2026 15:28:00 GMT</pubDate>
<description>Spire Healthcare Group plc announced on March 18, 2026, that executive directors Justin Ash and Harbant Samra were granted nil cost options under the Long Term Incentive Plan on March 17, 2026. Justin Ash received an award for up to 736,733 ordinary shares, and Harbant Samra received an award for up to 451,653 ordinary shares, with both awards representing 200% of their current base salary. The actual number of shares vesting will depend on performance conditions set to be finalized and publishe</description>
</item>
<item>
<title>Preliminary Results</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/preliminary-results-149</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/preliminary-results-149</guid>
<pubDate>Thu, 05 Mar 2026 07:00:00 GMT</pubDate>
<description>Spire Healthcare Group plc reported a resilient performance for the year ended 31 December 2025, with revenue increasing by 4.5% to £1,579.8 million and adjusted EBITDA growing by 3.2% to £268.6 million, despite significant cost headwinds. The company successfully implemented £30 million in savings through its transformation program, which included centralizing administration into patient support centers and optimizing staffing models. While private patient revenue saw a 1.7% increase, with self</description>
</item>
<item>
<title>Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/dimensional-fund-advisors-ltd-form-83-spire-healthcare-group-plc-ordinary-shares</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/dimensional-fund-advisors-ltd-form-83-spire-healthcare-group-plc-ordinary-shares</guid>
<pubDate>Tue, 24 Feb 2026 11:08:00 GMT</pubDate>
<description>FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of discloser:Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form 8.3. (b)Owner or controller of interests</description>
</item>
<item>
<title>Extension to deadline under Rule 2.6(c)</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/extension-to-deadline-under-rule-26c-1</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/extension-to-deadline-under-rule-26c-1</guid>
<pubDate>Wed, 18 Feb 2026 13:13:00 GMT</pubDate>
<description>Spire Healthcare Group plc announced an extension to the deadline for Bridgepoint Advisers Limited and Triton Investment Advisers LLP to make a firm offer or state their intention not to. The Takeover Panel has consented to this extension, moving the deadline from February 21, 2026, to March 21, 2026, allowing further time for ongoing discussions. The company remains in an "Offer Period" as defined by the Code, and further announcements will be made as appropriate.
Disclaimer*</description>
</item>
<item>
<title>Statement regarding media speculation</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/statement-regarding-media-speculation-1</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/statement-regarding-media-speculation-1</guid>
<pubDate>Mon, 26 Jan 2026 07:08:00 GMT</pubDate>
<description>Spire Healthcare Group plc has confirmed that Bridgepoint Advisers Limited and Triton Investment Advisers LLP are among parties in discussions regarding a strategic review, though these discussions are preliminary and no firm offer has been made. Both Bridgepoint and Triton are required to announce a firm intention to make an offer or state they do not intend to by 5:00 p.m. on February 21, 2026, unless an extension is granted by the Panel on Takeovers and Mergers.
Disclaimer*</description>
</item>
<item>
<title>Block listing Interim Review</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/block-listing-interim-review-94</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/block-listing-interim-review-94</guid>
<pubDate>Mon, 12 Jan 2026 10:57:00 GMT</pubDate>
<description>Spire Healthcare Group plc has reported a six-monthly return for its SAYE Option 2016 (Sharesave) scheme, indicating that as of January 10, 2026, there remains a balance of 1,021,397 unallotted securities. This balance is unchanged from the previous return, as no new securities were added to the scheme and no securities were issued or allotted during the period from July 11, 2025, to January 10, 2026.
Disclaimer*</description>
</item>
<item>
<title>Director Declaration</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/director-declaration-107</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/director-declaration-107</guid>
<pubDate>Fri, 09 Jan 2026 10:14:00 GMT</pubDate>
<description>Spire Healthcare Group plc announced that Non-Executive Director Jill Anderson will join the board of Croda International Plc as a Non-Executive Director effective 12 January 2026, also becoming a member of Croda's Audit, Nomination, and Remuneration committees. No further disclosures are required under UKLR 6.4.9R.
Disclaimer*</description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/holdings-in-company-203</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/holdings-in-company-203</guid>
<pubDate>Thu, 11 Dec 2025 16:53:00 GMT</pubDate>
<description>FIL Limited has reduced its total holding in Spire Healthcare Group PLC to 4.913000%, comprising 4.483600% of voting rights attached to shares and 0.429400% through financial instruments, specifically CFDs settled in cash. This change, which occurred on December 10, 2025, represents a decrease from their previous notification where their total holding was 5.103200%. The total number of voting rights held by FIL Limited is 19,787,507.
Disclaimer*</description>
</item>
<item>
<title>Trading Update</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/trading-update-81</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/trading-update-81</guid>
<pubDate>Wed, 03 Dec 2025 07:00:00 GMT</pubDate>
<description>Spire Healthcare Group plc announced a trading update indicating positive revenue growth of 3.6% year-on-year from July to October 2025, with its transformation program on track to deliver £30 million in savings. Despite improvements in self-pay trends, a slowdown in NHS commissioning is expected to result in full-year adjusted Group EBITDA for FY25 being at the bottom end of the £270 million to £285 million guidance range. For FY26, adjusted Group EBITDA is anticipated to be broadly in line or </description>
</item>
<item>
<title>Response to speculation</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/response-to-speculation-5</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/response-to-speculation-5</guid>
<pubDate>Fri, 19 Sep 2025 06:00:00 GMT</pubDate>
<description>Spire Healthcare Group PLC is actively evaluating options to drive long-term shareholder value, including a potential sale of the company. The company has commenced discussions with several parties, guided by Rothschild & Co, regarding these potential options. However, this process is preliminary, and no decision has been made about pursuing any specific option. There is no certainty that any offer will be made for the company, nor are there any discussions ongoing regarding a potential sale at </description>
</item>
<item>
<title>Half-year Report</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/half-year-report-592</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/half-year-report-592</guid>
<pubDate>Thu, 31 Jul 2025 06:00:00 GMT</pubDate>
<description>Half-year Report.</description>
</item>
<item>
<title>Appointment of Joint Corporate Broker</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/appointment-of-joint-corporate-broker-142</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/appointment-of-joint-corporate-broker-142</guid>
<pubDate>Wed, 16 Jul 2025 14:00:00 GMT</pubDate>
<description>Appointment of Joint Corporate Broker.</description>
</item>
<item>
<title>Result of AGM</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/result-of-agm-862</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/result-of-agm-862</guid>
<pubDate>Wed, 14 May 2025 14:23:00 GMT</pubDate>
<description>Result of AGM.</description>
</item>
<item>
<title>AGM Trading Statement</title>
<link>https://6ix.com/company/spire-healthcare-group-plc/news/agm-trading-statement-34</link>
<guid isPermaLink="true">https://6ix.com/company/spire-healthcare-group-plc/news/agm-trading-statement-34</guid>
<pubDate>Wed, 14 May 2025 06:00:00 GMT</pubDate>
<description>AGM Trading Statement.</description>
</item>
</channel>
</rss>